Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Craft 1861 is a wellness and lifestyle company specializing in the development and distribution of hemp-derived CBD products. The company focuses on clinical-grade formulations, emphasizing rigorous testing and zero-THC content to appeal to professional athletes and highly regulated industries. Their product portfolio includes topicals, tinctures, and other recovery-focused items designed to address pain and inflammation. Craft 1861 has established significant visibility through exclusive partnerships with major sporting entities such as IndyCar and MotoGP. By bridging the gap between traditional consumer goods and research-backed wellness, the company aims to set a high standard for transparency in the cannabinoid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Craft 1861.